logo

Crowdly

Browser

Add to Chrome

MFAC1523-Health Maintenance A 2026

Looking for MFAC1523-Health Maintenance A 2026 test answers and solutions? Browse our comprehensive collection of verified answers for MFAC1523-Health Maintenance A 2026 at moodle.telt.unsw.edu.au.

Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!

Question 4: The sternal angle indicates the position of?

participant with sternal angle labelled
View this question

Question 2: How many electrodes are positioned on the subject? 

(Type a number between 1 and 99)

different types of electrodes

View this question

Question 1: Who can be a subject for this class?

examination bench with leads for ECG and Pillow for volunteer
View this question

Atenolol is an antagonist with no intrinsic sympathomimetic activity, while pindolol is a partial agonist with intrinsic sympathomimetic activity.

Why were you unable to observe the submaximal efficacy of pindolol in the datasets? Select the correct answer(s).

View this question

Atenolol is a selective β1-adrenoceptor antagonist while pindolol is a non-selective β-adrenoceptor antagonist. Select the correct statement(s) below.

View this question

The effects of β-adrenoceptor blockade on exercise-induced changes in the cardiovascular and autonomic nervous system

In the graph below, data for atenolol and placebo are taken from the collated practical classes in 2022, while data for pindolol was obtained from a previous cohort of students.

Graph showing the effects of beta-blockers on perceived exertion during exercise

Figure 6: The effect of β-adrenoceptor antagonists on perceived exertion during exercise (fatigue) in healthy individuals over time. Placebo (vitamin B6, 10 mg), atenolol (50 mg) or pindolol (10 mg) were administered at 0 min. Data shown as mean ± s.e.m. * p<0.05 drug vs placebo (ANOVA); n = 41-73 per treatment.

In your practical class, you learned that β-adrenoceptor blockade increase fatigue during exercise. What is a possible explanation for the unchanged fatigue level observed for atenolol in this graph?

View this question

The effects of β-adrenoceptor blockade on exercise-induced changes in the cardiovascular and autonomic nervous system

In the graph below, data for atenolol and placebo are taken from the collated practical classes in 2022, while data for pindolol was obtained from a previous cohort of students.

Graph showing the effect of beta blockers on perceived exertion during exercise

Figure 6: The effect of β-adrenoceptor antagonists on perceived exertion during exercise (fatigue) in healthy individuals over time. Placebo (vitamin B6, 10 mg), atenolol (50 mg) or pindolol (10 mg) were administered at 0 min. Data shown as mean ± s.e.m. * p<0.05 drug vs placebo (ANOVA); n = 41-73 per treatment.

Briefly describe the data shown

View this question

The effects of β-adrenoceptor blockade on exercise-induced changes in the cardiovascular and autonomic nervous system

Predict the effect of β-adrenoceptor blockade on fatigue at rest and during exercise.

View this question

The effects of β-adrenoceptor blockade on lung function

In the graph below, data for atenolol and placebo are taken from the collated practical classes in 2022, while data for pindolol was obtained from a previous cohort of students.

Graph showing the effect of beta-blockers on peak flow at rest

Figure 5: The effect of β-adrenoceptor antagonists on resting peak expiratory flow rate (PEFR) of healthy individuals over time. Placebo (vitamin B6, 10 mg), atenolol (50 mg) or pindolol (10 mg) were administered at 0 min. Data shown as mean ± s.e.m. * p<0.05 drug vs placebo (ANOVA); n = 41-73 per treatment.

There are large error bars in the data set shown. Suggest several factors that may contribute to this.

View this question

The effects of β-adrenoceptor blockade on lung function

In the graph below, data for atenolol and placebo are taken from the collated practical classes in 2022, while data for pindolol was obtained from a previous cohort of students.

Graph showing the effect of beta-blockers on peak flow at rest

Figure 5: The effect of β-adrenoceptor antagonists on resting peak expiratory flow rate (PEFR) of healthy individuals over time. Placebo (vitamin B6, 10 mg), atenolol (50 mg) or pindolol (10 mg) were administered at 0 min. Data shown as mean ± s.e.m. * p<0.05 drug vs placebo (ANOVA); n = 41-73 per treatment.

Briefly describe the data shown.

View this question

Want instant access to all verified answers on moodle.telt.unsw.edu.au?

Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!

Browser

Add to Chrome